Market Research Life Sciences Market Research Medical Devices Market Research Manufacturing & Packaging Market Research

Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 200 Pages GlobalData August, 2024 GBDT19176692
Best Price Guarantee
Price from $4,000
Length 200 Pages
Publisher GlobalData
Published Date August, 2024
SKU GBDT19176692

Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transcatheter Aortic Valve Replacement (TAVR) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve. The procedure is largely performed transfemorally (through the groin) but can also be performed via alternative pathways including the transapical, transaortic, transcarotid, transsubclavian and transcaval approaches.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Aortic Valve Replacement (TAVR) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valve Replacement (TAVR) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valve Replacement (TAVR) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Transcatheter Aortic Valve Replacement (TAVR) Overview
  • Products under Development
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
    • Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
  • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products under Development by Companies
    • Transcatheter Aortic Valve Replacement (TAVR) Companies - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valve Replacement (TAVR) Companies - Pipeline Products by Stage of Development
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
  • Transcatheter Aortic Valve Replacement (TAVR) Companies and Product Overview
    • Aegis Surgical Limited Company Overview
      • Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table pTAo-TAVR - Product Status
        • Table pTAo-TAVR - Product Description
    • Anteris Technologies Ltd Company Overview
      • Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DurAVR THV System - Product Status
        • Table DurAVR THV System - Product Description
        • Table Anteris Technologies Ltd - Ongoing Clinical Trials Overview
        • Table DurAVR THV System - A Pivotal Study to Evaluate the Efficacy of DurAVR THV System for the Treatment Aortic Stenosis
        • Table DurAVR THV System - DurAVR THV System in a Valve-in-Valve Procedure: A First Successful Implantation in Humans
        • Table DurAVR THV System - DurAVR THV System: European Early Feasibility Study
        • Table DurAVR THV System - Use of DurAVR THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
        • Table DurAVR THV System - Use of DurAVR THV System in Subjects with Severe Aortic Stenosis: First In Human Study
    • AorTx, Inc. Company Overview
      • AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTx Valve - Product Status
        • Table AorTx Valve - Product Description
    • Arbor Surgical Technologies, Inc. Company Overview
      • Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trilogy Aortic Valve System - Product Status
        • Table Trilogy Aortic Valve System - Product Description
    • Atlas Medical Company Overview
      • Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endurance Valve - Product Status
        • Table Endurance Valve - Product Description
    • Beijing Balance Medical Technology Co Ltd Company Overview
      • Beijing Balance Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beijing Balance Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renatus - Product Status
        • Table Renatus - Product Description
    • Biotronik AG Company Overview
      • Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table BIOVALVE Resheathable Transcatheter Aortic Valve - Product Status
        • Table BIOVALVE Resheathable Transcatheter Aortic Valve - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACURATE neo2 Transfemoral TAVR System - Product Status
        • Table ACURATE neo2 Transfemoral TAVR System - Product Description
        • Table Gen 4 Lotus Valve System - Product Status
        • Table Gen 4 Lotus Valve System - Product Description
        • Table Lotus Edge Sheath 15F - Product Status
        • Table Lotus Edge Sheath 15F - Product Description
        • Table Lotus Edge Valve System - 21mm - Product Status
        • Table Lotus Edge Valve System - 21mm - Product Description
        • Table Lotus Edge Valve System - 29mm - Product Status
        • Table Lotus Edge Valve System - 29mm - Product Description
        • Table LOTUS Mantra - Product Status
        • Table LOTUS Mantra - Product Description
        • Table NG ACURATE - Product Status
        • Table NG ACURATE - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table ACURATE neo2 Transfemoral TAVR System - ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects Indicated for TAVR
        • Table ACURATE neo2 Transfemoral TAVR System - ACURATE neo2 Post Market Clinical Follow up Study
        • Table ACURATE neo2 Transfemoral TAVR System - Project to Look for Early Discharge in Patients Undergoing TAVI With ACURATE - An International Multi-center Early Discharge TAVI Program
        • Table ACURATE neo2 Transfemoral TAVR System - Prospective Evaluation Complementing Investigation with Acurate Neo Device
        • Table ACURATE neo2 Transfemoral TAVR System - Prospective, Randomized, Cost-utility Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Brazil
        • Table ACURATE neo2 Transfemoral TAVR System - PROVE ACURATE neo2 - Post Market Safety and Performance Surveillance in Aortic Stenosis
        • Table ACURATE neo2 Transfemoral TAVR System - Randomized Study Comparing Both Latest Generation Self-expanding Valves and Local Anesthesia Vs. Conscious Sedation in Transcatheter Aortic Valve Implantation
        • Table ACURATE neo2 Transfemoral TAVR System - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
    • Carena Healthcare Ltd Company Overview
      • Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pillar 3D Printed Replacement Heart Valve - Product Status
        • Table Pillar 3D Printed Replacement Heart Valve - Product Description
    • Chengdu Silara Meditech Inc Company Overview
      • Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve System - Product Status
        • Table Transcatheter Aortic Valve System - Product Description
        • Table Chengdu Silara Meditech Inc - Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve System - A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System in Patients with Severe Aortic Stenosis with or without Moderate or Lower Degree Regurgitation
        • Table Transcatheter Aortic Valve System - A Prospective, Multicenter, Single-arm Target-value Clinical Trial To Evaluate the Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
        • Table Transcatheter Aortic Valve System - To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Symptomatic Aortic Insufficiency
    • Colibri Heart Valve LLC Company Overview
      • Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri TAVI System - Product Status
        • Table Colibri TAVI System - Product Description
        • Table Delta Aortic Heart Valve - Product Status
        • Table Delta Aortic Heart Valve - Product Description
        • Table Second-Generation TAVI System - Product Status
        • Table Second-Generation TAVI System - Product Description
        • Table Venibri Transcatheter Heart Valve System - Product Status
        • Table Venibri Transcatheter Heart Valve System - Product Description
        • Table Colibri Heart Valve LLC - Ongoing Clinical Trials Overview
        • Table Colibri TAVI System - A Prospective, Single Arm Clinical Investigation Evaluating Safety and Performance of the Colibri Transcatheter Aortic Heart Valve System for the Treatment of Symptomatic Severe Aortic Stenosis Via Transfemoral Access in High Surgical Risk Patients
    • ContiTech (Beijing) Medical Technology Co Ltd Company Overview
      • ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Balloon-Expandable Transcatheter Aortic Valve Replacement Device - Product Status
        • Table Balloon-Expandable Transcatheter Aortic Valve Replacement Device - Product Description
    • Daidalos Solutions BV Company Overview
      • Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Status
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Description
    • Direct Flow Medical Inc (Inactive) Company Overview
      • Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Status
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Description
        • Table 22F Percutaneous Aortic Valve System - Product Status
        • Table 22F Percutaneous Aortic Valve System - Product Description
    • Dongguan Tiantianxiang Medical Technology Co Ltd Company Overview
      • Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAVR - Cardiovascular - Product Status
        • Table TAVR - Cardiovascular - Product Description
    • DSM Dyneema BV Company Overview
      • DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Status
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Description
    • Dura LLC Company Overview
      • Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LowPro Valve - Product Status
        • Table LowPro Valve - Product Description
    • Edwards Lifesciences Corp Company Overview
      • Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Gen CENTERA - Product Status
        • Table Next Gen CENTERA - Product Description
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Product Status
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Product Description
        • Table SAPIEN 3 THV - Moderate Aortic Stenosis - Product Status
        • Table SAPIEN 3 THV - Moderate Aortic Stenosis - Product Description
        • Table SAPIEN X4 - Product Status
        • Table SAPIEN X4 - Product Description
        • Table Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
        • Table SAPIEN 3 THV - Moderate Aortic Stenosis - Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD)
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Risk of Coronary Obstruction Due to Sinus Sequestration by Redo Transcatheter Aortic Valve Implantation in Japanese Patients with SAPIEN 3
        • Table SAPIEN X4 - Prospective, Single Arm, Multicentre, Feasibility Study to Demonstrate the Safety and Functionality of the Edwards 12f Sheath Introducer Set In Conjunction with the Sapien X4 Transcatheter Heart Valve (THV) In Subjects with Symptomatic, Severe, Calcific Aortic Stenosis (AS) (Protocol Number: 2023-06)
        • Table SAPIEN X4 - Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve
        • Table SAPIEN X4 - Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve - Mitral
    • Endoluminal Technology Research LLC Company Overview
      • Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Balloon Expandable Paniagua Heart Valve - Product Status
        • Table Balloon Expandable Paniagua Heart Valve - Product Description
    • Florida International University Company Overview
      • Florida International University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Florida International University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Aortic Heart Valve - Product Status
        • Table Percutaneous Aortic Heart Valve - Product Description
    • Folda LLC Company Overview
      • Folda LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Folda LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Foldavalve - Product Status
        • Table Foldavalve - Product Description
    • Foldax Inc Company Overview
      • Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tria Transcatheter Aortic Valve Replacement Device - Product Status
        • Table Tria Transcatheter Aortic Valve Replacement Device - Product Description
    • HLT, Inc. Company Overview
      • HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meridian II Transcatheter Aortic Valve Replacement System - Product Status
        • Table Meridian II Transcatheter Aortic Valve Replacement System - Product Description
        • Table HLT, Inc. - Ongoing Clinical Trials Overview
        • Table Meridian II Transcatheter Aortic Valve Replacement System - Study to Evaluate the Safety and Performance of HLT Meridian TAVR Valve System in the Treatment of Aortic Regurgitation
        • Table Meridian II Transcatheter Aortic Valve Replacement System - Study to Evaluate the Safety and Performance of HLT Meridian TAVR Valve System in the Treatment of Aortic Stenosis
    • JC Medical, Inc. Company Overview
      • JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table J-Valve TAVI System - Transapical - Product Status
        • Table J-Valve TAVI System - Transapical - Product Description
        • Table J-Valve TF System - Product Status
        • Table J-Valve TF System - Product Description
        • Table JC Medical, Inc. - Ongoing Clinical Trials Overview
        • Table J-Valve TF System - J-Valve Compassionate Use Cases
        • Table J-Valve TF System - J-Valve TF Early Feasibility Study
        • Table J-Valve TF System - J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy
    • JenaValve Technology GmbH Company Overview
      • JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - Product Status
        • Table JenaValve Pericardial TAVR System - Product Description
        • Table Trilogy Heart Valve System - Product Status
        • Table Trilogy Heart Valve System - Product Description
        • Table JenaValve Technology GmbH - Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - A Study to Assess Safety and Effectiveness of the JenaValve Trilogy Heart Valve System in the Treatment of High Surgical Risk Patients with Symptomatic, Severe Aortic Regurgitation (AR)
        • Table JenaValve Pericardial TAVR System - THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation (AR)
        • Table Trilogy Heart Valve System - A Prospective, Multicenter, Single-group Clinical Study to Evaluate the Safety and Efficacy of Peijia Medical Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Regurgitation
        • Table Trilogy Heart Valve System - Trilogy Heart Valve System for Management of Patients with Aortic Valve Disease: Patient Registry and Post-market Clinical Follow-up Study
    • Jenscare Scientific Co Ltd Company Overview
      • Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ken-Valve - Product Status
        • Table Ken-Valve - Product Description
        • Table KenFlex - Product Status
        • Table KenFlex - Product Description
    • Jinshi Biotechnology (Changshu) Co Ltd Company Overview
      • Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve Replacement Device - Product Status
        • Table Transcatheter Aortic Valve Replacement Device - Product Description
    • KOKA Lifesciences Co Ltd Company Overview
      • KOKA Lifesciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table KOKA Lifesciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Koka Valve - Product Status
        • Table Koka Valve - Product Description
        • Table KOKA Lifesciences Co Ltd - Ongoing Clinical Trials Overview
        • Table Koka Valve - A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis
    • Laguna Tech USA Inc Company Overview
      • Laguna Tech USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laguna Tech USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alpha Self-Expanding Aortic Valve system - Product Status
        • Table Alpha Self-Expanding Aortic Valve system - Product Description
        • Table Zeta Balloon Expandable Aortic Valve System - Product Status
        • Table Zeta Balloon Expandable Aortic Valve System - Product Description
        • Table Laguna Tech USA Inc - Ongoing Clinical Trials Overview
        • Table Zeta Balloon Expandable Aortic Valve System - First-in-Human Clinical Study of Zeta Balloon Expandable Aortic Valve System in Patients at High Surgical Risk With Severe Aortic Regurgitation
        • Table Alpha Self-Expanding Aortic Valve system - First-in-Human Clinical Trial of Alpha Transcatheter Aortic Valve Replacement (TAVR) System for the Treatment of Aortic Regurgitation
    • Lepu Medical Technology (Beijing) Co Ltd Company Overview
      • Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sinocrown Transcatheter Aortic Valve Replacement System - Product Status
        • Table Sinocrown Transcatheter Aortic Valve Replacement System - Product Description
        • Table Transcatheter Aortic Valve Replacement System - Product Status
        • Table Transcatheter Aortic Valve Replacement System - Product Description
        • Table Transcatheter Aortic Valve System (Balloon Dilation) - Product Status
        • Table Transcatheter Aortic Valve System (Balloon Dilation) - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Aortic Valve - Product Status
        • Table Percutaneous Aortic Valve - Product Description
    • Medtronic Plc Company Overview
      • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evolut Next Gen - Product Status
        • Table Evolut Next Gen - Product Description
    • Meril Life Sciences Pvt Ltd Company Overview
      • Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MyVal S/Ex - Product Status
        • Table MyVal S/Ex - Product Description
    • MicroPort CardioFlow Medtech Corp Company Overview
      • MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table VitaFlow Balloon Expandable - Product Status
        • Table VitaFlow Balloon Expandable - Product Description
        • Table VitaFlow III - Product Status
        • Table VitaFlow III - Product Description
        • Table VitaFlow Novo Generation - Product Status
        • Table VitaFlow Novo Generation - Product Description
    • Nanjing Saint Medical Technology Co Ltd Company Overview
      • Nanjing Saint Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanjing Saint Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve System - Product Status
        • Table Transcatheter Aortic Valve System - Product Description
        • Table Xcor - Product Status
        • Table Xcor - Product Description
        • Table Nanjing Saint Medical Technology Co Ltd - Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve System - To Evaluate the Efficacy and Safety of Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Stenosis
    • NewMed Medical Co Ltd Company Overview
      • NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prizvalve II TAVR Valve - Product Status
        • Table Prizvalve II TAVR Valve - Product Description
        • Table Prizvalve Pro TAVR Valve - Product Status
        • Table Prizvalve Pro TAVR Valve - Product Description
        • Table Prizvalve System - Product Status
        • Table Prizvalve System - Product Description
        • Table Starr-A TAVR Valve - Product Status
        • Table Starr-A TAVR Valve - Product Description
        • Table NewMed Medical Co Ltd - Ongoing Clinical Trials Overview
        • Table Prizvalve System - An Exploratory Study to Evaluate the Prizvalve System in Patients With Failing Bioprosthetic Valve
        • Table Prizvalve System - An Exploratory Study to Evaluate the Prizvalve System in Patients with Severe Atrioventricular Annular Calcification or Failed Prosthetic Atrioventricular Valve/ Annulus Repair
        • Table Prizvalve System - Evaluation of the Efficacy and Safety of the Transcatheter Aortic Valve Replacement System in Patients with Severe Aortic Valve Stenosis Disease at High Surgical Risk
        • Table Prizvalve Pro TAVR Valve - Evaluation of the Safety and Efficacy of the Prizvalve Pro Transcatheter Aortic Valve System in the Treatment of Patients With Severe Aortic Valve Stenosis Disease at High Surgical Risk
    • Novogate Medical Ltd. Company Overview
      • Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wisefix System - Transcatheter Aortic Valve Implantation - Product Status
        • Table Wisefix System - Transcatheter Aortic Valve Implantation - Product Description
    • NVT GmbH Company Overview
      • NVT GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table NVT GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table ALLEGRA Plus Transcatheter Heart Valve (THV) System - Product Status
        • Table ALLEGRA Plus Transcatheter Heart Valve (THV) System - Product Description
        • Table NVT GmbH - Ongoing Clinical Trials Overview
        • Table ALLEGRA Plus Transcatheter Heart Valve (THV) System - Investigation of the Safety and Performance of the NVT ALLEGRA Plus THV System in Patients With Severe aortic Stenosis or Failed surgical Aortic bioprosthesis
    • P+F Products + Features GmbH Company Overview
      • P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vienna Aortic Self-Expandable Transcatheter Valve - Product Status
        • Table Vienna Aortic Self-Expandable Transcatheter Valve - Product Description
        • Table P+F Products + Features GmbH - Ongoing Clinical Trials Overview
        • Table Vienna Aortic Self-Expandable Transcatheter Valve - A Two -Stage First in Human (FIH) Feasibility / Pivotal Study of the Vienna Aortic Valve SE System
    • Peca Labs Inc Company Overview
      • Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fully Synthetic Transcatheter Valve - Product Status
        • Table Fully Synthetic Transcatheter Valve - Product Description
    • Peijia Medical Ltd Company Overview
      • Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peijia Balloon Expandable Valve - Product Status
        • Table Peijia Balloon Expandable Valve - Product Description
        • Table TaurusApex Polymer Leaflets TAVR System - Product Status
        • Table TaurusApex Polymer Leaflets TAVR System - Product Description
        • Table TaurusNXT - Product Status
        • Table TaurusNXT - Product Description
        • Table Peijia Medical Ltd - Ongoing Clinical Trials Overview
        • Table TaurusNXT - A Multi-center, Prospective Study to Evaluate the Safety and Efficacy of TaurusNXT TAVR System for Treating Calcific Severe Aortic Stenosis
    • PolyNova Cardiovascular Inc Company Overview
      • PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Status
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Description
    • RegenaGraft Company Overview
      • RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synthetic Heart Valve - Product Status
        • Table Synthetic Heart Valve - Product Description
    • ReValve Med Inc Company Overview
      • ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Aortic Valve - Product Status
        • Table Removable Transcatheter Aortic Valve - Product Description
    • SAS Cormove Company Overview
      • SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cormove Percutaneous Aortic Valve - Product Status
        • Table Cormove Percutaneous Aortic Valve - Product Description
    • Shanghai Healing Medical Instruments Co Ltd Company Overview
      • Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HanchorValve - Product Status
        • Table HanchorValve - Product Description
        • Table Transcatheter Aortic Valve Replacement Device - Product Status
        • Table Transcatheter Aortic Valve Replacement Device - Product Description
        • Table Shanghai Healing Medical Instruments Co Ltd - Ongoing Clinical Trials Overview
        • Table HanchorValve - A Multi-center Clinical Study of HanchorValve to Treat Patients with Severe Aortic Regurgitation
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Product Status
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Product Description
        • Table St. Jude Medical LLC - Ongoing Clinical Trials Overview
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Evaluation of the Portico NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
    • Stony Brook University Company Overview
      • Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation TAVR Valve - Product Status
        • Table Next Generation TAVR Valve - Product Description
    • Strait Access Technologies (Pty) Ltd Company Overview
      • Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAT TAVI System - Product Status
        • Table SAT TAVI System - Product Description
    • Suzhou Jiecheng Medical Technology Co Ltd Company Overview
      • Suzhou Jiecheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Suzhou Jiecheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jiecheng Transvascular Interventional Biological Aortic Valve - Product Status
        • Table Jiecheng Transvascular Interventional Biological Aortic Valve - Product Description
    • Symetis SA Company Overview
      • Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACURATE Prime - Product Status
        • Table ACURATE Prime - Product Description
        • Table ACURATE Prime XL Transfemoral Aortic Valve System - Product Status
        • Table ACURATE Prime XL Transfemoral Aortic Valve System - Product Description
        • Table ACURATE TAo - Product Status
        • Table ACURATE TAo - Product Description
    • The University of British Columbia Company Overview
      • The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
        • Table The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomaterial Heart Valve - Product Status
        • Table Biomaterial Heart Valve - Product Description
    • Thubrikar Aortic Valve, Inc. Company Overview
      • Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optimum TAVI System - Product Status
        • Table Optimum TAVI System - Product Description
        • Table Thubrikar Aortic Valve, Inc. - Ongoing Clinical Trials Overview
        • Table Optimum TAVI System - A First-in-human Study to Access Feasibility and Safety of the Optimum Aortic Valve Implant
        • Table Optimum TAVI System - Efficacy and Safety of Optimum TAVI System in Subjects with Severe Aortic Stenosis: A First-in-Human Study
    • University College London Company Overview
      • University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRISKELE Aortic Valve - Product Status
        • Table TRISKELE Aortic Valve - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve - Product Status
        • Table Transcatheter Aortic Valve - Product Description
    • University of Cambridge Company Overview
      • University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Valve - Product Status
        • Table Removable Transcatheter Valve - Product Description
    • University of Iowa Company Overview
      • University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellulose Based Aortic Heart Valve - Product Status
        • Table Cellulose Based Aortic Heart Valve - Product Description
    • University of Pennsylvania Company Overview
      • University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aortic Repair Device - Product Status
        • Table Aortic Repair Device - Product Description
    • Valve Medical Ltd. Company Overview
      • Valve Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Valve Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xemed TAVR Device - Product Status
        • Table Xemed TAVR Device - Product Description
        • Table Valve Medical Ltd. - Ongoing Clinical Trials Overview
        • Table Xemed TAVR Device - First in Human Study of the GEMINUS Transcatheter Aortic Valve Implantation System in Patients with Severe Symptomatic Aortic Stenosis
    • Vascular Concepts Ltd Company Overview
      • Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Status
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Description
    • Venus Medtech Hangzhou Inc Company Overview
      • Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AR Valve - Product Status
        • Table AR Valve - Product Description
        • Table Transapical Trinity Aortic Valve Implantation System - Product Status
        • Table Transapical Trinity Aortic Valve Implantation System - Product Description
        • Table Transfemoral Trinity Aortic Valve Implantation System - Product Status
        • Table Transfemoral Trinity Aortic Valve Implantation System - Product Description
        • Table Venus PowerX Valve - Product Status
        • Table Venus PowerX Valve - Product Description
        • Table Venus Vitae Valve - Product Status
        • Table Venus Vitae Valve - Product Description
        • Table Venus Medtech Hangzhou Inc - Ongoing Clinical Trials Overview
        • Table Venus Vitae Valve - A First-in-man Clinical Trial of Venus Vitae Valve in Patients with Heart Valvular Disease
        • Table Venus Vitae Valve - Multicenter Pivotal Study to Evaluate the Treatment of Severe Aortic Valve Stenosis With Next-Generation Venus-Vitae Transcatheter Heart Valve (THV) System
    • Xeltis AG Company Overview
      • Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Heart Valve - Product Status
        • Table Transcatheter Aortic Heart Valve - Product Description
    • Youngheartvalve LLC Company Overview
      • Youngheartvalve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Youngheartvalve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polymeric Trans-Catheter Aortic Valve - Product Status
        • Table Polymeric Trans-Catheter Aortic Valve - Product Description
  • Transcatheter Aortic Valve Replacement (TAVR)- Recent Developments
    • Aug 09, 2024: No Evidence to Support the Variation in Price the NHS Is Paying for Valves Used in Keyhole Heart Procedures
    • Jul 01, 2024: Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip Passes Animal Study
    • Jun 24, 2024: The Landmark RCT marks a milestone for Meril's Myval THV series
    • Jun 18, 2024: Anteris Provides Update on Pivotal Trial Submission US FDA has provided positive eedback on key elements of the study design
    • Jun 17, 2024: CardioFlow's VitaFlow Liberty Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
    • Jun 13, 2024: Anteris Provides Update on DurAVR THV Valve-In-Valve Experience Presented at New York Valves 2024
    • Jun 13, 2024: Medtronic Confirms Global Layoffs
    • Jun 11, 2024: Anteris Provides Data Update on First in Human Study of DurAVR THV Presented at New York Valves 2024
    • Jun 07, 2024: New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance
    • Jun 06, 2024: MiRus Siegel TAVR: First in Human Results Presented at New York Valves
    • Jun 05, 2024: Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
    • May 22, 2024: MicroPort Donates Medical Devices for El Salvador's First TAVI in a Public Hospital
    • May 08, 2024: Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe with Technology to Enhance Durability
    • May 06, 2024: Thubrikar Aortic Valve Announces Clinical Success of the New Precision 2 Delivery Catheter
    • Apr 18, 2024: Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement
    • Apr 17, 2024: International Study Compares Self-Expanding and Balloon-Expandable Transcatheter Aortic-Valve Replacement in Patients with Small Aortic Annulus
    • Apr 07, 2024: SMART Trial One-Year Data Demonstrates Medtronic Evolut TAVR Platform as Optimal Treatment for Severe Aortic Stenosis in Patients with Small Annulus, which Is Primarily Women
    • Apr 07, 2024: Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
    • Apr 06, 2024: egnite and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
    • Mar 28, 2024: JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
    • Mar 27, 2024: Medtronic Announces FDA Approval of Newest-Generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
    • Mar 19, 2024: Jenavalve's Trilogy THV System Highlighted at CRT 2024
    • Mar 13, 2024: Edwards presents positive data from two valve studies at CRT 2024
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Mar 11, 2024: New late-breaking data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-Effectiveness Benefits of TAVR Platform
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 13, 2024: Interventional Cardiology at Adventist Health Glendale Reaches Milestone with 500th TAVR Procedure
    • Feb 06, 2024: Genesis MedTech concludes US J-Valve study enrollment
    • Jan 29, 2024: Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Jan 04, 2024: EISENHOWER HEALTH BECOMES FIRST EDWARDS BENCHMARK PROGRAM OBSERVATION SITE FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BEGINS HOSTING TAVR TEAMS FROM ACROSS THE NATION
    • Jan 03, 2024: Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial
    • Dec 15, 2023: Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2 Delivery Catheter
    • Dec 04, 2023: Colibri's valve shows superior haemodynamics in pilot study
    • Nov 20, 2023: MicroPort CardioFlow Completes Five Pre-Market Implantations of VitaFlow Liberty in Denmark
    • Oct 27, 2023: Japan Lifeline Enters into Exclusive Distribution Agreement with Meril Life Sciences for Myval Octacor Transcatheter Heart Valve in Japan
    • Oct 24, 2023: JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
    • Oct 24, 2023: Medtronic Evolut TAVRPlatform Outperforms Surgery With Sustained Valve Performance for Low-Risk Patients at Four Years
    • Oct 24, 2023: Five-Year Data From Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve
    • Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
    • Oct 12, 2023: Medtronic Receives CE Mark for Evolut FX TAVI System for Treatment of Severe Aortic Stenosis
    • Sep 19, 2023: JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023
    • Sep 11, 2023: Multiple MicroPort Business Groups Make an Appearance at SOLACI-SBHCI 2023
    • Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

$4,000
$8,000
$12,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings